Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer
Conditions: Stage II Colon Cancer; Stage III Colon Cancer Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Eloxatin | Research